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تقييم سرعة الرتشيح الكبييب ىف املرضى العمانيني باستخدام معادلة 
كوككروفت-جولت و معادلة تعديل النظام الغذائى ملرضى الكلى
جمدي عيد �لع�صيلي و �صامل �صعيد �لق�صابى و �صعود حممد �حلارثي
abstract: Objectives: Glomerular filtration rate (GFR) is the best index of renal function and is frequently 
assessed by corrected creatinine clearance (CCLcr). The limitations of CCLcr have inspired researchers to derive 
easy formulas to estimate GFR, with Cockcroft-Gault (C-G) and the modification of diet in renal disease (MDRD) 
being the most widely used. This study aimed to evaluate the validity of these equations by finding the relation 
between CCLcr and estimated GFR (eGFR) by C-G, modified C-G and MDRD equations. Methods: From 2007 to 
2011, 158 subjects were analysed for serum creatinine and CCLcr at Bowsher Polyclinic, Muscat, Oman. The C-G 
equation was used to obtain eGFRC-G which was adjusted to body surface area (BSA) to obtain eGFRmC-G, and the 
MDRD equation was used to obtain eGFRMDRD. The eGFRMDRD, eGFRmC-G and eGFRC-G were then compared to 
CCLcr. Results: The eGFRMDRD, eGFRmC-G and eGFRC-G significantly correlated with CCLcr, with a slightly stronger 
correlation with eGFRMDRD (r = 0.701, 0.658 and 0.605, respectively). A receiver operating characteristic curve 
analysis showed that the diagnostic accuracy of eGFRMDRD for diagnosing chronic kidney disease (CKD) was higher 
than that of eGFRmC-G, which in turn was higher than that of eGFRC-G (area under the curve was 0.846, 0.831, 
and 0.791; cut-off limits were 61.9, 58.3 and 59.5, respectively). Conclusion: C-G and MDRD equations can be an 
alternative to the CCLcr test for assessing GFR, thus avoiding the need for the cumbersome and expensive GFR test. 
The MDRD formula had greater validity than the C-G equation and the C-G equation validity was improved by an 
adjustment to BSA.
Keywords: Creatinine; Glomerular Filtration Rate; Diet Modification; Chronic Kidney Disease; Oman.
امللخ�ص: الهدف: يعد ح�صاب �رشعة �لرت�صيح �لكبيبي و�لذي يقا�س عن طريق ��صتخال�س �لكرياتيني من �أف�صل �ملوؤ�رش�ت لوظائف �لكليتي. ونظر� ل�صلبيات 
تعد معادلة  و  �لكرياتيني.  ��صتخال�س  تعتمد على  �لكبيبي ال  �لرت�صيح  ��صطر�لباحثون ال�صتقاق معادالت حل�صاب �رشعة  �لكرياتيني,  ��صتخال�س  طريقة 
�أكرث هذه �ملعادالت �صيوعا. �لغر�س من هذه �لدر��صة هو تقييم هذه �ملعادالت عن  كوككروفت-جولت ومعادلة تعديل �لنظام �لغذ�ئي ملر�صى �لكلى من 
طريق �إيجاد �لعالقة بي ��صتخال�س �لكرياتيني وكل من �رشعة �لرت�صيح �لكبيبي عن طريق معادلة كوككروفت-جولت و �رشعة �لرت�صيح �لكبيبي عن طريق 
لقد  الطريقة:  �لكلى.  �لغذ�ئي ملر�صى  �لنظام  �لكبيبي عن طريق معادلة تعديل  �لرت�صيح  معادلة كوككروفت-جولت �ملعدلة مل�صاحة �صطح �جل�صم و �رشعة 
�أجريت هذه �لدر��صة يف جممع بو�رش �لتخ�ص�صي يف حمافظة م�صقط يف عمان )�لفرتة من عام 2007و حتى عام 2011(. و مت قيا�س ن�صبة �لكرياتيني 
بالدم و كمية ��صتخال�س �لكرياتيني يف بول 24 �صاعة يف �ملر�صى �مل�صاركي يف �لدر��صة و عددهم مائة و ثمانية و خم�صون مري�صا. مت ح�صاب �رشعة 
�لرت�صيح �لكبيبي عن طريق معادلة كوككروفت-جولت و�رشعة �لرت�صيح �لكبيبي عن طريق معادلة كوككروفت-جولت �ملعدلة مل�صاحة �صطح �جل�صم و �رشعة 
�لرت�صيح �لكبيبي عن طريق معادلة تعديل �لنظام �لغذ�ئي ملر�صى �لكلى جلميع �ملر�صى ثم مت در��صة �لعالقة بي ��صتخال�س �لكرياتيني و بي و �رشعة 
�لرت�صيح �لكبيبي عن طريق �ملعادالت �لثالثة. النتائج: تبي �نه يوجد �رتباط كبريبي كل من �رشعة �لرت�صيح �لكبيبي عن طريق معادلة تعديل �لنظام �لغذ�ئي 
ملر�صى �لكلى و�رشعة �لرت�صيح �لكبيبي عن طريق معادلة كوككروفت-جولت �ملعدلة و�رشعة �لرت�صيح �لكبيبي عن طريق معادلة كوككروفت-جولت و بي 
��صتخال�س �لكرياتيني)معامل �الرتباط= 0.701 و0.658 و0.605 بالرتتيب( و �أظهر منحنى خ�صائ�س �لت�صغيل �أن قدرة �رشعة �لرت�صيح �لكبيبي عن 
طريق معادلة تعديل �لنظام �لغذ�ئى ملر�صى �لكلى لت�صخي�س مر�س �لكلى �ملزمن �أعلى من قدرة �رشعة �لرت�صيح �لكبيّب عن طريق معادلة كوككروفت-جولت 
�ملعدلة مل�صاحة �صطح �جل�صم و �لذي بدوره �أعلى من �رشعة �لرت�صيح �لكبيبي عن طريق معادلة كوككروفت- جولت )�ملنطقه حتت �ملنحنى كانت 0.846و 
0.831و0.791و حدود �لقطع كانت 61.9 و58.3 و59.5 بالرتتيب( اخلال�سة: تعد معادلة كوككروفت-جولت و معادلة تعديل �لنظام �لغذ�ئى ملر�صى 
�لكلى بديل عن �ختبار ��صتخال�س �لكرياتيني لقيا�س �رشعة �لرت�صيح �لكبيبي مما يوؤدي �إىل جتنب �صعوبة و تكلفة هذ� �الختبار. وتعد معادلة تعديل �لنظام 
�لغذ�ئى ملر�صى �لكلى �أكرث دقة من معادلة كوككروفت-جولت �ملعدلة مل�صاحة �صطح �جل�صم و �لتي بدورها �أكرث دقة من معادلة كوككروفت-جولت �الأ�صلية.
مفتاح الكلمات: �لكرياتيني؛ �رشعة �لرت�صيح �لكبيبي؛ تعديل �لنظام �لغذ�ئي؛ مر�س �لكليتي �ملزمن؛ عمان.
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Glomerular filtration rate (GFR) is considered the best index of renal function as it assesses the progression 
of kidney dysfunction. The normal value is ~130 
and 120 ml/min/1.73 m² for men and women, 
respectively, depending on age, sex and body size.1 
GFR can be determined by measuring the clearance 
of exogenous (inulin, 125-iothalamate, 51 Cr-
ethylene diamine tetra acetic acid [EDTA], 99mTc-
diethylene triamine penta acetic acid [DTPA] and 
iohexol) or endogenous (creatinine) substances.2 
Methods using exogenous substances  are expensive, 
time-consuming, risky and cannot be easily 
implemented in clinical practice. Nevertheless, 
inulin clearance is the gold standard test for GFR as 
it is freely filtered and is not secreted, reabsorbed, 
synthesised or metabolised by the kidney.3 
Creatine clearance (CLcr) is an alternative 
to inulin clearance. Creatinine is freely filtered 
and is not metabolised by the kidney; however, 
it is secreted by the renal tubules.4 If the effect 
of secretion is ignored, then all of the filtered 
creatinine will be excreted and this will reflect the 
GFR. Thus the GFR and CLcr will be equal: [UCr x 
V]/SCr,5 where UCr is urine creatinine, V is the 24-
hour urine volume and SCr is the serum creatinine. 
However, CLcr tends to exceed the true GFR due to 
tubular secretion.5 It should therefore be adjusted to 
body surface area (BSA) so as to obtain the corrected 
creatinine clearance (CCLcr) in ml/min/1.73 m² by 
the following equation:6
The normal value of CCLcr is 95 ± 20 ml/min per 
1.73 m² in women and 120 ± 25 ml/min per 1.73 m2 
in men.5 
SCr varies inversely with GFR and is used 
to assess stable kidney function, as a rise in SCr 
represents a reduction in GFR. However, in acute 
renal failure, GFR is markedly reduced and there is 
no time for creatinine to accumulate.6 The mean SCr 
values for men and women are 100 and 82 µmol/L, 
respectively. These values vary by race and differ 
according to its production, secretion, extrarenal 
excretion and assay.7,8
The limitations of CLcr and inulin clearance 
have inspired researchers to seek out easy  formulas 
to estimate GFR (eGFR).9 The most widely used 
formulas are Cockcroft-Gault (C-G)10 and the 
modification of diet in renal disease (MDRD).11 
These formulas include variables such as age, sex, 
race, weight and SCr. In adults, normal eGFR is 
≥90 ml/min/1.73m². Chronic kidney disease (CKD) 
is defined by an eGFR of <60 ml/min/1.73 m2.9 As 
for SCr, the proper interpretation of these equations 
requires stable kidney function, and its accuracy is 
also limited as SCr is affected by factors other than 
creatinine filtration.12,13
In the C-G equation, CLcr can be estimated by 
the following formula:10
This formula should be adjusted for BSA to 
increase its accuracy and compare normal values.14 
It appears to be less accurate in the obese, those of 
different ethnicities, different age groups, children 
and pregnant women.1
The original MDRD equation has six variables, 
including urea and albumin which was a limitation 
Advances in Knowledge
- Methods using exogenous substances to assess renal function are expensive, time-consuming, risky and  cannot be easily implemented 
in clinical practice. Additionally, creatinine clearance (CLcr) has some limitations. Due to the limitations of the clearance tests, they 
are frequently replaced by estimation equations such as Cockcroft-Gault (C-G) and the modification of diet in renal disease (MDRD) 
formulas.
- In this study, the MDRD formula had greater validity than the C-G equation and the C-G equation validity was improved by an 
adjustment to body surface area.
Applications to Patient Care
- The knowledge that C-G and MDRD equations can be used as an alternative to the CLcr test for assessing GFR will enable the patient 
to avoid the time-consuming, cumbersome and expensive CLcr test.
- It will be easier for the clinician to follow the progress of kidney disease by assessing eGFR with these equations, depending on patient age, 
weight and serum creatinine. It will also circumvent the need for 24-hour urine collection.
- The MDRD formula is recommended to assess eGFR in patients with chronic kidney disease as it has greater validity than the C-G 
equation.
CCLcr = (CLcr x 1.73)
             BSA
CLcr (ml/min) = (140 - age in years ) x (weight 
in Kg) x 1.23 if male (1.04 if female)/SCr in µmol/L
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eGFR (ml/min per 1.73 m2) = 1.75 x SCr-1.154 x age-
0.203 x 1.212 (if of African descent) x 0.742 (if female), 
where SCr is in µmol/L and age in years
for the added cost and analytical variation.13 
Recognising this, the MDRD-4 variable equation 
was developed based on SCr, age, gender and 
ethnicity by the following formula:15 
This study was conducted primarily to evaluate 
the performance of C-G and MDRD equations in 
Omani patients by finding out the relation between 
CCLcr and eGFR by using C-G (eGFRC-G), modified 
C-G (eGFRmC-G ) and MDRD (eGFRMDRD) equations. 
Secondly, we sought to replace the CLcr test with 
eGFR for the assessment of kidney function in 
clinical practice, thereby avoiding the need for the 
time-consuming, cumbersome and expensive CLcr 
test.
Methods
This cross-sectional analytical study was carried out 
at Bowsher Polyclinic, Muscat, Oman, by auditing 
the files of subjects reporting to the Internal 
Medicine Clinic for a CLcr test to assess kidney 
function from 1 January 2007 to 30 April 2011. 
Ethical approval was received from the Regional 
Research & Ethics Committee of the Directorate 
General & Health Services of the Muscat Region.
The inclusion criteria included adult patients 
who reported to the Internal Medicine Clinic at 
Polyclinic for a CLcr test. However, patients who 
had incomplete data or dialysis therapy were 
excluded; thus 97 of the 255 files reviewed could 
not be considered, leaving a total of 158 subjects. 
Demographic data, such as age, gender, weight, 
height, body mass index (BMI) and BSA, were 
recorded.
All subjects were analysed for SCr and subjected 
to 24-hour urine collection to estimate urine 
volume (V) and urine creatinine (UCr). The CLcr 
was calculated by the following equation:5
The CLcr was then adjusted to BSA to get CCLcr 
in ml/min per 1.73 m² by the following formula, 
where BSA equals the square root ([height in cm x 
weight in Kg]/3600):8,16
Depending on a patient’s gender, age and SCr, 
C-G was used to obtain the predicted CLcr, which 
was abbreviated as eGFRC-G, as in the following 
formula:10
The eGFRC-G (ml/min) was adjusted to BSA 
(modified C-G) to obtain eGFRmC-G (ml/min per 
1.73 m²): eGFRmC-G = eGFRC-G x 1.73/BSA.
The MDRD-4 variable equation was used to 
obtain eGFRMDRD in ml/min per 1.73 m² by the 
following formula:15
The eGFRC-G, eGFRmC-G and eGFRMDRD were 
compared to CCLcr and statistical analysis was done 
to find out the correlation between them and to 
estimate an agreement between them. Data were 
coded using the Statistical Package for the Social 
Sciences (SPSS), Version 15 (IBM, Corp., Chicago, 
Illinois, USA) and summarised using the mean, 
standard deviation (SD), minimal and maximum 
values for quantitative variables and number and 
percentage for qualitative values. Correlations were 
done to test for linear relations between variables. 
Logistic regression analysis was done to test for 
significant predictors of dependent variables. A 
receiver operating characteristic (ROC) curve 
was used to test the validity of scores calculated 
by regression equations. A P value of ≤0.05 was 
considered statistically significant.
Results
The subjects in the study (N = 158) were 
predominantly <70 years of age (n = 115), although 
43 were ≥70 years. The gender distribution was 
nearly equal (85 males and 73 females) and 42 were 
obese while 116 were not considered obese. Of those 
included in the study, 99 had diabetes (DM) and 59 
were non-diabetic. The mean ± SD (range) age was 
61.65 ± 10.46 (34.0–82.0); BMI was 27.93 ± 5.89 
(16.6–54.6); SCr was 108.23 ± 47.12 (28.0–373.0); 
CCLcr was 69.52 ± 37.28 (10.30–196.5); eGFRMDRD 
was 62.89 ± 27.52 (14.0–206.0); eGFRmC-G was 66.37 
± 28.09 (18.3–154.3), and eGFRC-G was 66.87 ± CCLcr =(CLcr x 1.73)
               BSA
       CCLcr (ml/min)=(UCr x V)
                             SCr
eGFRC-G (ml/min) = (140 - age in years) x (weight 
in Kg) x 1.23 if male (1.04 if female )/SCr in µmol/L.
eGFRMDRD = 175 x SCr-1.154 x age-0.203) x 1.212 (if of 
African descent) x 0.742 (if female), where SCr is in 
µmol/L and age in years. None of our patients were 
of African descent.
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30.54 (20.21–163.92) of the studied subjects.
The eGFRMDRD, eGFRmC-G and eGFRC-G 
correlated significantly with CCLcr, with a slightly 
stronger correlation with eGFRMDRD (r = 0.701, 
0.658 and 0.605, respectively; P <0.001).
Studying eGFRMDRD, eGFRmC-G and eGFRC-G at 
a known cut-off value of 90 found that eGFRmC-G
had a higher validity than eGFRC-G and that 
eGFRMDRD had a higher sensitivity and lower 
specificity than either eGFRmC-G or eGFRC-G 
(sensitivity = 97.4, 93.6 and 92.3; specificity = 22.5%, 
27.5% and 26.3%,  respectively).
The ROC curve analysis showed that the 
diagnostic accuracy of eGFRmC-G for a diagnosis 
of CKD was higher than that of eGFRC-G. The 
eGFRMDRD had a higher area under the curve (AUC) 
and higher sensitivity and lower specificity than 
either eGFRC-G or eGFRmC-G [Figure 1 and Table 1].
Regression analysis was performed to predict 
renal impairment by using eGFRC-G adjusted for 
age, sex, obesity and DM. A regression equation 
was applied to calculate the predicted score for each 
patient (ranging from 0–100). The predicted score 
was entered in a ROC curve to detect its validity 
as well as to determine the best cut-off value for 
diagnosing renal impairment. The same was done 
for eGFRmC-G and eGFRMDRD for comparison. A 
ROC curve analysis showed that the eGFRmC-G score 
had a higher AUC, sensitivity, negative predictive 
value (NPV) and total accuracy (TA), and lower 
specificity and positive predictive value (PPV) than 
the eGFRC-G score. Additionally, the eGFRMDRD 
score had a higher validity than the eGFRmC-G score 
[Figure 2 and Table 2].
Regarding the validity among the studied 
groups, the eGFRMDRD  had a higher validity than 
either eGFRC-G or eGFRmC-G in the obese, diabetic, 
male or the ≥70-year-old subjects. Comparing the 
validity of eGFRmC-G and eGFRC-G, this study also 
showed that eGFRmC-G had higher validity in the 
Table 1: The validity of eGFRC-G, eGFRmC-G and eGFRMDRD as a diagnostic tool for renal impairment after receiver 
operating characteristic curve analysis
AUC P value Cut-off 
values*
Sensitivity Specificity PPV NPV TA
eGFRC-G 0.791 <0.001 ≤59.5 73.1 80.0 78.1 75.3 76.6
eGFRmC-G 0.831 <0.001 ≤58.3 75.6 85.0 83.1 78.2 80.4
eGFRMDRD 0.846 <0.001 ≤61.9 82.1 72.5 74.4 80.6 77.2
AUC = area under the curve; PPV = positive predictive value; NPV = negative predictive value; TA = total accuracy; eGFRC-G = estimated glomerular 
filtration rate by Cockcroft-Gault equation; eGFRmC-G = estimated glomerular filtration rate by modified Cockcroft-Gault equation; eGFRMDRD = 
estimated glomerular filtration rate by modification of diet in renal disease.
*mg/min for eGFRC-G and mg/min/1.73 m2 for eGFRmC-G and eGFRMDRD .
Figure 1: The validity of eGFRC-G , eGFRmC-G and 
eGFRMDRD as a diagnostic tool for renal impairment 
after receiver operating characteristic curve analysis.
eGFRC-G = estimated glomerular filtration rate by Cockcroft-
Gault equation; eGFRmC-G = estimated glomerular filtration rate 
by modified Cockcroft-Gault equation; eGFRMDRD = estimated 
glomerular filtration rate by modification of diet in renal disease.
Figure 2: Receiver operating characteristic curve for 
eGFRC-G , eGFRmC-G and eGFRMDRD for the assessment 
of kidney function after adjustment for age, sex, weight 
and diabetes mellitus*.
eGFRC-G = estimated glomerular filtration rate by Cockcroft-
Gault equation; eGFRmC-G = estimated glomerular filtration rate 
by modified Cockcroft-Gault equation; eGFRMDRD = estimated 
glomerular filtration rate by modification of diet in renal disease.
*Predicted probability 1 by eGFRC-G ; predicted probability 2 by 
eGFRmC-G ; predicted probability 3 by eGFRMDRD .
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≥70-year-old, male and diabetic subjects; however, 
in the obese subjects, eGFRmC-G was more sensitive 
but had less specificity, PPV, NPV and TA than in 
eGFRC-G [Table 3].
Discussion
GFR is the best index of renal function in health and 
disease. It can be estimated by measuring the renal 
clearance of certain substances using exogenous 
(radioisotopic and non-radioisotopic) filtration 
markers. However, these methods are impractical 
and expensive.17 Endogenous markers such as 
creatinine have also been used to assess GFR. The 
accuracy of CLcr may be limited by inaccurate urine 
collection and creatinine secretion. Not only is 
urine collection time-consuming and cumbersome, 
but incomplete collection leads to a reduced CLcr 
while over-collection leads to an increased CLcr.8 
Moreover, CLcr overestimates the GFR due to 
tubular creatinine secretion.5 To compensate for 
these previous limitations, investigators have 
devised equations that predict GFR based on SCr, 
gender, body size, race and age. The most widely 
used equations are the C-G equation, which 
produces GFR values in ml/min, and the MDRD 
equation, which produces GFR values in ml/min 
per 1.73 m².18 The C-G equation should be adjusted 
for BSA to increase its accuracy and enable a 
comparison with normal values.14
In this study, we evaluated the performance of 
the C-G and MDRD equations for estimating the 
GFR in a cohort of 158 subjects. An important 
characteristic of the cohort is that it included 
subjects whose CCLcr ranged from 10.3–196.5 ml/
min per 1.73 m² with sufficient numbers of subjects 
having CCLcr >60 and <60 (84 and 74, respectively). 
Thus, the performance of these equations could 
be assessed over a wide range of kidney function. 
Furthermore, because all patients included in this 
study were Arab, the performances of the C-G and 
MDRD equations could be assessed in a group of 
subjects whose anthropometric characteristics 
are slightly different from those of American or 
European subjects.
With these different anthropometric 
characteristics in mind, we compared eGFRMDRD, 
eGFRmC-G and eGFRC-G with CCLcr. It was found that 
these equations underestimated GFR in comparison 
to CCLcr (mean CCLcr, eGFRMDRD, eGFRmC-G and 
eGFRC-G were 69.52, 62.89, 66.37 and 66.87, 
respectively). This can be explained by the fact 
that CCLcr exceeds the true GFR by 19% because 
of tubular  secretion.5 In their study, Froissart et al. 
showed that there was a very good global agreement 
between measured GFR and both eGFRMDRD and 
eGFRmC-G. On average, eGFRMDRD was only 1.0 ml/
min per 1.73 m² less than measured GFR; eGFRmC-G 
was only 1.9 ml/min per 1.73 m² greater than 
measured GFR. However, Froissart et al.’s study 
compared eGFRMDRD and eGFRmC-G against GFR 
measured by 51Cr-EDTA renal clearance, and not 
CCLcr, and did not evaluate eGFRC-G.19 Similarly, in 
1999, Levey et al. documented that the C-G formula 
largely overestimated measured GFR.13
The current study demonstrated that eGFRMDRD, 
eGFRmC-G and eGFRC-G can replace CCLcr in 
practice, avoiding the limitations of CCLcr, as 
evidenced by the significant correlation between 
them, with a stronger correlation with eGFRMDRD 
(r = 0.701, 0.658 and 0.605, respectively; P <0.001). 
These results are supported by a Pakistani study 
which compared eGFRMDRD and eGFRC-G with 
CCLcr in 369 cases, revealing a significant correlation 
between them, with a stronger correlation with 
eGFRMDRD (r = 0.788 for eGFRMDRD and r = 0.775 
for eGFRC-G). However, that study did not evaluate 
eGFRmC-G.18 In 2006, Shoker et al. compared 
Table 2: The validity of eGFRC-G, eGFRmC-G and eGFRMDRD as a diagnostic tool for the assessment of kidney function 
after adjustment for age, sex, weight and diabetes
AUC P value Cut-off 
values*
Sensitivity Specificity PPV NPV TA
eGFRC-G 0.806 <0.001 ≥48.7 80.8 73.8 75.0 79.7 77.2
eGFRmC-G 0.841 <0.001 ≥46.3 84.6 71.3 74.2 82.6 77.8
eGFRMDRD 0.853 <0.001 ≥48.4 84.6 73.8 75.9 83.1 79.1
AUC = area under the curve; PPV = positive predictive value; NPV = negative predictive value; TA = total accuracy; eGFRC-G = estimated glomerular 
filtration rate by Cockcroft-Gault equation; eGFRmC-G = estimated glomerular filtration rate by modified Cockcroft-Gault equation; eGFRMDRD = 
estimated glomerular filtration rate by modification of diet in renal disease.
*mg/min for eGFRC-G and mg/min/1.73 m2 for eGFRmC-G and eGFRMDRD .
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eGFRmC-G and eGFRC-G with CCLcr, documenting 
that eGFRmC-G gave superior results compared to 
eGFRC-G, with an overall accuracy in the general and 
subgroup analysis.14 Similarly, our results showed 
that eGFRmC-G had a stronger correlation with CCLcr 
than eGFRC-G emphasising that the correction for 
BSA increases the validity of the C-G equation. 
The difference between the two studies is that 
eGFRmC-G and eGFRC-G were compared with CLcr in 
the Shoker et al. study, but in our study they were 
compared with CCLcr, which is more accurate. In 
2012, Alcântara et al. compared eGFRC-G with CCLcr 
and no significant difference was found between the 
mean eGFRC-G (64.7 ± 27.4) and the mean CCLcr 
(68.4 ± 32.6) and a correlation between them was 
found (r = 0.68; P <0.001). Using lean body weight 
instead of total body weight to obtain the eGFRC-G, 
the correlation coefficient was increased to 0.75 
(P <0.001).20 However, Alcântara et al.’s study did not 
evaluate eGFRmC-G and eGFRMDRD, as in our study.
In studying eGFRMDRD, eGFRmC-G and eGFRC-G 
as a diagnostic tool for renal impairment, as 
Table 3: The validity of eGFRC-G, eGFRmC-G and eGFRMDRD in diagnosing renal impairment among different studied 
groups
Variable eGFR Group Sensitivity Specificity PPV NPV TA
Age eGFRC-G <70 76.5 84.4 79.6 81.8 80.9
eGFRmC-G <70 82.4 81.3 77.8 85.2 81.7
eGFRMDRD <70 82.4 79.7 76.4 85.0 80.9
eGFRC-G ≥70 88.9 31.3 68.6 62.5 67.4
eGFRmC-G ≥70 88.9 31.3 68.6 62.5 67.4
eGFRMDRD ≥70 88.9 50.0 75.0 72.7 74.4
Sex eGFRC-G F 83.8 72.2 75.6 81.3 78.1
eGFRmC-G F 83.8 72.2 75.6 81.3 78.1
eGFRMDRD F 83.8 72.2 75.6 81.3 78.1
eGFRC-G M 78.0 75.0 74.4 78.6 76.5
eGFRmC-G M 85.4 70.5 72.9 83.8 77.6
eGFRMDRD M 85.4 75.0 76.1 84.6 80.0
BMI eGFRC-G Not 81.8 78.7 77.6 82.8 80.2
eGFRmC-G Not 85.5 77.0 77.0 85.5 81.0
eGFRMDRD Not 83.6 77.0 76.7 83.9 80.2
eGFRC-G Obese 78.3 57.9 69.2 68.8 69.0
eGFRmC-G Obese 82.6 52.6 67.9 71.4 69.0
eGFRMDRD Obese 87.0 63.2 74.1 80.0 76.2
DM eGFRC-G DM 87.3 56.8 71.6 78.1 73.7
eGFRmC-G DM 89.1 56.8 72.1 80.6 74.7
eGFRMDRD DM 89.1 61.4 74.2 81.8 76.8
eGFRC-G No DM 65.2 94.4 88.2 81.0 83.1
eGFRmC-G No DM 73.9 88.9 81.0 84.2 83.1
eGFRMDRD No DM 73.9 88.9 81.0 84.2 83.1
eGFR = estimated glomerular filtration rate; PPV = positive predictive values; NPV = negative predictive value; TA = total accuracy; eGFRC-G 
= estimated glomerular filtration rate by Cockcroft-Gault equation; eGFRmC-G = estimated glomerular filtration rate by modified Cockcroft-Gault 
equation; eGFRMDRD = estimated glomerular filtration rate by modification of diet in renal disease; BMI = body mass index; F = female; M = male; DM 
= diabetes mellitus.
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detected by CCLcr and at a known cut-off value of 
90, it was found that eGFRmC-G had a higher validity 
than eGFRC-G. This emphasises that correction for 
BSA increases the validity of the C-G equation and 
that eGFRMDRD had a higher sensitivity and lower 
specificity than either eGFRmC-G or eGFRC-G. A ROC 
curve analysis showed that the diagnostic accuracy 
of eGFRmC-G for diagnosing CKD was higher than 
that of eGFRC-G, and that eGFRMDRD had a higher 
sensitivity, higher AUC and a lower specificity than 
either eGFRC-G or eGFRmC-G. By doing a regression 
analysis to predict renal impairment, using eGFRC-G, 
eGFRmC-G and eGFRMDRD adjusted for age, sex, 
obesity and DM, the ROC curve analysis showed 
that the eGFRmC-G score had a higher AUC, 
sensitivity, NPV and TA, and a lower specificity and 
PPV than that of the eGFRC-G score. Additionally, 
it showed that the eGFRMDRD score had a higher 
validity than the eGFRmC-G score. Our results 
supported those of Srinivas et al., whose study 
compared eGFRMDRD and eGFRmC-G with GFR 
measured by 99mTc-DTPA renal clearance in 
599 renal donors; this study demonstrated that 
eGFRMDRD performed better in terms of global 
bias, precision, correlation and accuracy than 
eGFRmC-G.21
Regarding the validity among studied groups, 
our study showed that eGFRMDRD had a higher 
validity than either eGFRC-G or eGFRmC-G in 
males, those with DM, individuals ≥70 years of 
age and those who were obese. The eGFRmC-G had 
higher validity in diabetics, males and  those ≥70 
years of age than eGFRC-G; however, in the obese 
subjects, eGFRmC-G was more sensitive but had less 
specificity, PPV, NPV and TA than eGFRC-G. This 
was similar to Froissart et al.’s study, which showed 
that eGFRmC-G had the lowest level of precision for 
obese subjects.19
In 2005, Rigalleau et al. compared eGFRMDRD 
and eGFRmC-G with measured GFR in 160 diabetic 
patients, and revealed that eGFRMDRD and eGFRmC-G 
correlated well with measured GFR, while eGFRMDRD 
underestimated and eGFRmC-G overestimated 
it. The ROC curve analysis showed that the 
maximum diagnostic accuracy of eGFRmC-G for 
diagnosing CKD was lower than that of eGFRMDRD. 
It was concluded that the MDRD equation is more 
accurate for the diagnosis of renal failure in diabetic 
patients.22 However, eGFRMDRD and eGFRmC-G were 
evaluated against measured GFR by 51Cr-EDTA 
clearance and not against CCLcr. The eGFRC-G was 
not evaluated.
Based on the current study, as well as other 
studies, it is clear that the measurement of CLcr 
using a 24-hour urine collection system does 
not improve the estimate of GFR compared to 
that provided by the C-G and MDRD equations. 
Nevertheless, this system provides useful 
information for the estimation of GFR in individuals 
with unsual dietary intake (for example in subjects 
with vegetarian diets or those taking creatine 
supplements), or abnormal muscle mass (for 
instance as a result of amputation, malnutrition or 
muscle wasting). It is also useful for the assessment 
of diet and nutritional status, and for assessing the 
patient’s status when there is a need to start dialysis.9
There are several limitations to this study. 
First, CLcr was used as the reference method for 
GFR although the measurement of CLcr has many 
theoretical and practical difficulties. Ideally it 
should be substituted by inulin or isotope clearances 
as a reference to verify the accuracy of the results. 
Second, it would be more relevant to compare C-G 
and MDRD formulas in a multicentre environment.
Conclusion
C-G and MDRD equations can be used as an 
alternative to the CLcr test for assessing GFR, 
thereby avoiding the cumbersome, time-consuming 
and expensive GFR test. The MDRD formula had 
better validity in this study than the C-G equation 
and the validity of the C-G equation was improved 
by an adjustment to the BSA.
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